-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for...
More »SEARCH RESULT
Cancer medication as low as Rs 1,000/month on way -Malathy Iyer
-The Times of India MUMBAI: It's widely known that a month's dose of cancer drugs can cost lakhs, but what isn't common knowledge is that Tata Memorial Hospital's doctors are working on alternatives that could cost less than Rs 1,000 a month. Dubbed the metronomic treatment protocol, it comprises daily consumption of a combination of low-dose medicines that are cheap because they have been around for decades. "There is no need to...
More »Armed with whistle-blower policy, Ranbaxy to look ahead-Sushmi Dey
-The Business Standard Patient safety & quality our guidance now, says Sawhney Trouble-hit Ranbaxy Laboratories has introduced a whistle-blower policy within the company to encourage transparency and address concerns internally, so that bigger problems could be averted. In his first interaction with the media (the first part of which was published on Sunday) since the drug maker pleaded guilty of making fraudulent statements to the US Food and Drugs Administration (FDA) under its...
More »A deception most foul-Narayan Lakshman
-The Hindu Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...
More »RTI brings to light drug trial on humans -Syed Intishab Ali
-The Times of India JAIPUR: A doctor conducted drug trial on heart patients but seven of them died during trial of the drug. Moreover, another doctor conducted drug trials of different companies and 10 of his cancer patients died during the trials. An RTI filed by a government-run Indore hospital Dr Anand Rai exposed deaths leading to drug trials in entire country. Answering to the RTI, office ofdrug controller general, ministry of...
More »